SCHEMBL23913437

SCHEMBL23913437

c1ccc(-c2cccc3oc4cc(-c5nc(-c6ccc(-c7ccc8sc9ccccc9c8c7)cc6)nc(-c6ccc7c(c6)oc6ccccc67)n5)ccc4c23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.35
HCRTR1 O43613 1/20 0.35
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
PRKDC P78527 1/20 0.34
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
F9 P00740 1/20 0.33
BACE1 P56817 1/20 0.33
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
SLC9A1 P19634 1/20 0.33
PLA2G10 O15496 1/20 0.32
LIMK1 P53667 1/20 0.32
AHR P35869 1/20 0.32
MAPT P10636 1/20 0.31
ALOX5 P09917 2/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25458796 0.98 PIM3 (0.37) PIM3HCRTR1MMP12MMP13PRKDC
SCHEMBL23228094 0.98 PIM3 (0.37) PIM3HCRTR1MMP12MMP13PRKDC
SCHEMBL23913825 0.97 HCRTR1 (0.35) PIM3HCRTR1MMP12MMP13PRKDC
SCHEMBL21116824 0.97 PRKDC (0.36) PIM3HCRTR1MMP12MMP13PRKDC
SCHEMBL23913436 0.95 HCRTR1 (0.35) PIM3HCRTR1MMP12MMP13PRKDC
SCHEMBL23821599 0.95 PRKDC (0.35) PIM3HCRTR1PRKDCPLA2G2APLA2G4A
SCHEMBL21116819 0.95 PRKDC (0.35) PIM3HCRTR1MMP12PRKDCPLA2G2A
SCHEMBL23228089 0.95 PRKDC (0.37) PIM3HCRTR1MMP12MMP13PRKDC
SCHEMBL25459330 0.95 PRKDC (0.37) PIM3HCRTR1MMP12MMP13PRKDC
SCHEMBL24264346 0.94 PRKDC (0.36) PIM3HCRTR1MMP12PRKDCPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 PIM3 3253/4885HCRTR1 476/4885MMP12 4705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.